Cancer: Drugs
(asked on 16th December 2015) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what proportion of the NHS budget was spent on (a) generic and (b) branded cancer medicines for each of the last five years.
Information on National Health Service expenditure and expenditure on branded and generic cancer drugs is provided in the table. Information on the cost of other non-drug treatments for cancer is not held in the format requested.
Proportions have not been provided as the information on cancer drug expenditure may not represent what was actually paid for the drugs by the NHS. The net ingredient cost shown for drugs in primary care is the basic cost of a drug. It does not take account of discounts, dispensing costs, fees or prescription charges income. The cost of secondary care drugs is the cost at NHS list price and will not necessarily be the price the hospital paid.
Year | Total NHS revenue expenditure – outturn (£ million) | Cancer drugs expenditure – primary care (£ million) 1 | Cancer drugs1 expenditure – secondary care (£ million) 1 | Total cancer drugs1 expenditure (£ million) 1,2 | ||||
Branded | Generic | Total | Branded | Generic | Total | |||
2010-11 | 97,469 | 207 | 21 | 228 | 640 | 206 | 846 | 1,074 |
2011-12 | 100,266 | 136 | 54 | 190 | 710 | 247 | 957 | 1,148 |
2012-13 | 102,570 | 122 | 20 | 142 | 874 | 245 | 1,118 | 1,260 |
2013-14 | 106,495 | 121 | 22 | 143 | 1,078 | 262 | 1,340 | 1,483 |
2014-15 | 110,554 | 120 | 27 | 147 | 1,314 | 300 | 1,614 | 1,761 |
Source: Department of Health: Prescription Cost Analysis and IMS Health: Hospital Pharmacy Audit Index provided by the Health and Social Care Information Centre.
Notes:
1 as classified in British National Formulary section 8.1 Cytotoxic drugs, section 8.3 Sex hormones and hormone antagonists in malignant disease, paragraph 8.2.3 Anti-lymphocyte monoclonal antibodies (but also used in other indications) and paragraph 8.2.4 Other immunomodulating drugs (interferon-alfa, aldesleukin, bacillus calmette-guerin, lenalidomide, pomalidomide, thalidomide and mifamurtide only).
2 Total figures may not sum due to rounding.